ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP)

Historical Holders from Q1 2014 to Q2 2023

Type / Class
Equity / COM NEW
Symbol
ADMP
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2023 Q2 0 $0 -$3,195,693 0
2023 Q1 27,578,755 $3,195,693 +$1,705,942 11.59% 44
2022 Q4 12,741,369 $2,156,772 -$33,597 16.93% 43
2022 Q3 12,823,714 $2,545,000 -$86,573 19.82% 35
2022 Q2 12,859,141 $6,443,000 -$47,872 50% 41
2022 Q1 12,899,392 $7,369,000 -$740,856 57.12% 41
2021 Q4 14,176,388 $8,575,000 -$682,762 60.5% 46
2021 Q3 15,061,394 $14,610,000 -$1,303,962 97.02% 50
2021 Q2 16,144,303 $17,757,000 +$3,206,701 110% 49
2021 Q1 12,547,614 $12,776,470 +$6,594,245 94.02% 50
2020 Q4 5,787,579 $3,799,243 -$772,748 48.6% 35
2020 Q3 6,618,469 $5,196,175 +$1,254,080 78.31% 43
2020 Q2 5,095,892 $2,736,581 -$387,096 53.78% 42
2020 Q1 6,965,947 $2,485,367 +$798,942 35.68% 35
2019 Q4 4,811,118 $3,372,322 -$2,970,243 70.02% 36
2019 Q3 9,032,560 $6,364,353 +$196,801 70.42% 47
2019 Q2 7,450,527 $9,686,650 -$2,693,014 130% 49
2019 Q1 9,222,968 $19,459,055 +$1,859,587 210.92% 54
2018 Q4 8,322,614 $18,725,490 -$6,193,078 225.05% 56
2018 Q3 10,581,307 $36,188,750 +$22,758,975 349.99% 56
2018 Q2 3,974,797 $12,730,680 +$1,583,226 320.24% 48
2018 Q1 3,469,108 $12,140,750 -$3,130,313 349.94% 51
2017 Q4 4,171,333 $18,361,000 -$8,087,326 440% 57
2017 Q3 5,551,793 $29,001,450 +$12,610,085 522.34% 45
2017 Q2 3,180,729 $16,541,000 +$1,204,840 519.97% 44
2017 Q1 2,990,172 $12,711,000 +$1,643,747 425% 28
2016 Q4 2,817,673 $8,877,000 -$531,836 314.89% 33
2016 Q3 2,916,450 $10,000,000 +$3,126,702 342.82% 34
2016 Q2 2,027,777 $5,673,000 -$3,161,496 279.5% 29
2016 Q1 2,600,831 $15,941,000 -$991,957 612.68% 25
2015 Q4 2,757,389 $14,888,160 +$288,430 539.9% 25
2015 Q3 2,726,432 $10,620,000 +$462,722 387.91% 25
2015 Q2 2,604,122 $10,937,280 +$512,582 420.02% 28
2015 Q1 2,487,733 $9,800,456 +$2,231,779 394.08% 28
2014 Q4 1,912,518 $11,799,808 -$727,052 617% 21
2014 Q3 959,221 $4,487,680 -$1,031,975 467.93% 19
2014 Q2 1,174,963 $5,650,000 -$3,625,860 481.07% 19
2014 Q1 1,672,276 $10,634,000 -$2,328,045 635.94% 18